Business Context and Reporting Period
This Form 8-K Current Report was filed by Vistagen Therapeutics, Inc. on July 12, 2024, covering events occurring on July 8, 2024. The filing primarily addresses a change in the Company's independent registered public accounting firm.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the administrative change of the external auditor.
Material Changes
- Dismissal of Auditor: The Company dismissed WithumSmith+Brown, PC ("Withum") as its independent registered public accounting firm, effective July 8, 2024.
- Engagement of New Auditor: The Company engaged KPMG LLP ("KPMG") to serve as its new independent registered public accounting firm for the fiscal year ending March 31, 2025, effective July 8, 2024.
- Audit History: Withum's reports for fiscal years ended March 31, 2024, and March 31, 2023, contained no adverse opinions or disclaimers. The 2023 report included a going concern uncertainty paragraph, which was absent in the 2024 report.
- No Disagreements: The Company confirmed there were no disagreements or reportable events with Withum regarding accounting principles, financial statement disclosures, or audit scope during the relevant periods.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of operational risks. The change in auditors was the result of a competitive selection process conducted by the Audit Committee. The Company confirmed that no consultations regarding accounting principles or audit opinions were held with KPMG prior to their engagement.
Investor Verification Checklist
- Verify the effective date of the auditor transition (July 8, 2024) and the specific fiscal year KPMG will audit (ending March 31, 2025).
- Review the "Letter from WithumSmith+Brown, PC" (Exhibit 16.1) to confirm the auditor's concurrence with the Company's statements regarding the dismissal.
- Confirm the removal of the "going concern" explanatory paragraph in the most recent 10-K filed on June 11, 2024, as noted in the filing.
- Monitor future filings for the first financial statements audited by KPMG to ensure continuity in reporting standards.